Gene · 9567
Papers2,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Work-Related Musculoskeletal Disorders Risk Assessment during Manual Lymphatic Drainage with Compressive Bands among Physiotherapists. | Healthcare (Basel) | 2024 | 38201023 | PubTator, text mining | PubMed |
| Changes in tissue protein N-glycosylation and associated molecular signature occur in the human Parkinsonian brain in a region-specific manner. | PNAS Nexus | 2024 | 38178977 | PubTator, text mining | PubMed |
| "VR is the future": perspectives of healthcare professionals on virtual reality as a diagnostic tool for dementia status in primary care. | BMC Med Inform Decis Mak | 2024 | 38178165 | PubTator, text mining | PubMed |
| Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. | Nat Commun | 2024 | 38177144 | PubTator, text mining | PubMed |
| Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1. | Nat Commun | 2024 | 38167417 | PubTator, text mining | PubMed |
| Post reversible encephalopathy syndrome attributed to mycophenolate mofetil used in the treatment of SLE: A case report and review of literature. | J Int Med Res | 2024 | 38156668 | PubTator, text mining | PubMed |
| The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation. | J Biol Chem | 2024 | 38141764 | PubTator, text mining | PubMed |
| Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome. | Am J Hum Genet | 2024 | 38118446 | Swiss-Prot, curated | PubMed |
| Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): In-vitro, in-vivo, and in-silico approaches. | Saudi Pharm J | 2024 | 38090734 | PubTator, text mining | PubMed |
| Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay. | J Pept Sci | 2024 | 38031661 | PubTator, text mining | PubMed |
| Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN. | Br J Cancer | 2024 | 37951974 | PubTator, text mining | PubMed |
| Reducing long-term use of benzodiazepine receptor agonists: In-depth interview study with primary care stakeholders. | Health Expect | 2024 | 37849382 | PubTator, text mining | PubMed |
| Biomarkers in aortic dissection: Diagnostic and prognostic value from clinical research. | Chin Med J (Engl) | 2024 | 37620283 | PubTator, text mining | PubMed |
| A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus. | Appl Biochem Biotechnol | 2024 | 37479961 | PubTator, text mining | PubMed |
| Medical professionals' agency and pharmaceuticalization: Physician-industry relations in Russia. | Health (London) | 2024 | 35913030 | PubTator, text mining | PubMed |
| Topological invariance in whiteness optimisation. | Commun Phys | 2023 | 38665411 | PubTator, text mining | PubMed |
| Recent advances in infectious disease research using cryo-electron tomography. | Front Mol Biosci | 2023 | 38288336 | PubTator, text mining | PubMed |
| Age-Related Changes in Serum N-Glycome in Men and Women-Clusters Associated with Comorbidity. | Biomolecules | 2023 | 38254617 | PubTator, text mining | PubMed |
| Cardioneuroablation for the treatment of severe syncopal high-grade atrioventricular block following abdominal tumor surgery. | HeartRhythm Case Rep | 2023 | 38204829 | PubTator, text mining | PubMed |
"It depends on the people!" - A qualitative analysis of contextual factors, prior to the implementation of digital health innovations for chronic condition management, in a German integrated care network. | Digit Health | 2023 | 38162835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9567/papers?page=6